NEW YORK, Feb. 2, 2011 /PRNewswire/ -- That's Nice LLC, a brand and marketing management agency serving pharmaceutical and biotech markets for 14 years, announced today that its Nice Insight Pharmaceutical & Biotechnology Outsourcing Survey will launch on February 16, 2011.
That's Nice serves 300 marketing clients in the materials science and life science industries. The company is investing $2.5 million into its new Nice Insight brand, encompassing the design and deployment of the Pharmaceutical & Biotechnology Outsourcing Survey that will solicit input from up to 40,000 respected industry professionals, and collection and analysis of visual and messaging strategies employed by 400+ CRAMs companies.
This degree of commitment and investment will deliver two robust core product offerings, called 'Marcom Tracker' and 'Brand Index,' which will provide a level of marketing intelligence not currently available to companies in the Contract Research & Manufacturing (CRAMs) sector. The products will also benefit any company seeking to partner with the industry's innovators and developers.
Victor Coker, Director of Business Intelligence, said, "CRAMs and innovator companies need a practical and personalized evaluation of the market to enable them to more effectively align their communications and services with their potential partners. This is the only way to improve collaborations and enhance the prospective pipeline for life-changing drugs. While working in CRAMs, I was unable to access intelligence in this depth and format, so we're very excited about Nice Insight."
The 40,000 industry professionals canvassed in the Pharmaceutical & Biotechnology Outsourcing Survey represent Big Pharma, Mid-size Pharma, Virtual and Emerging Companies, and Small Biotechs. The Brand Index product consequently offers focused insight into innovator & investor perceptions of CRAMs providers and highlights the current needs of potential resear
|SOURCE That's Nice LLC|
Copyright©2010 PR Newswire.
All rights reserved